Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe

MeSH terms

• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / adverse effects*
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects*
• Cetuximab
• Colorectal Neoplasms / drug therapy
• Colorectal Neoplasms / pathology
• ErbB Receptors / antagonists & inhibitors*
• Humans
• Infusions, Intravenous
• Neoplasm Metastasis
• Panitumumab